From transcriptional regulation to drugging the cancer epigenome

James E Bradner1

  • 1Department of Medical Oncology, Dana-Farber Cancer Institute, and Department of Medicine, Harvard Medical School, Boston, MA 02115 USA.

Genome Medicine
|January 17, 2015
PubMed

Insights

This discussion covers the cancer epigenome, exploring challenges and opportunities in its study and therapeutic targeting. It also highlights innovative strategies for cancer drug discovery.

Area of Science:

  • Oncology
  • Epigenetics
  • Pharmacology

Background:

  • The cancer epigenome presents complex challenges and opportunities for therapeutic intervention.
  • Understanding epigenetic modifications is crucial for developing novel cancer treatments.

Purpose of the Study:

  • To discuss the current landscape of cancer epigenome research.
  • To explore innovative approaches in cancer drug discovery targeting epigenetic mechanisms.

Main Methods:

  • Review of current research and therapeutic strategies.
  • Discussion of emerging drug discovery paradigms.

Main Results:

  • Identification of key challenges in targeting the cancer epigenome.
  • Highlighting promising innovative approaches for drug development.

Conclusions:

  • The cancer epigenome offers significant therapeutic potential.
  • Innovative drug discovery is essential for realizing this potential in cancer treatment.

Related Concept Videos

Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
4.3K
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
34.6K
Epigenetic Regulation01:46

Epigenetic Regulation

26.7K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
11.7K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.5K